Video Experimental Relacionado
Updated: Jul 3, 2026

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling
Published on: April 2, 2012
Diseño de la Cápside AAV2 Guiado por Modelos Generativos de Proteínas en Tiempo de Prueba
Ben Viggiano1, Wenhui Sophia Lu2, Xiaowei Zhang3
1Department of Biomedical Data Science, Stanford University, Stanford, CA, USA.
Abstract:
Recent advances in protein generative models have created new opportunities for protein engineering. However, a significant challenge remains in effectively steering these models to generate sequences with specific, desired functionalities, especially when these properties are defined by "black-box" or non-differentiable fitness functions. To address this, we present ProVADA+, a model-agnostic framework that guides pretrained generative models at testtime without costly retraining. Our approach introduces a reinforcement learning-based adaptive masking technique (MADA-DUCB) that significantly accelerates convergence. We demonstrate this framework on the challenging task of designing novel Adeno-Associated Virus 2 (AAV2) capsids. By coupling a ProteinMPNN generative prior with a fine-tuned AAV viability oracle, our method successfully navigates the rugged fitness landscape where unguided random mutagenesis is ineffective-with prior experiments showing as few as 0.3% of variants with six or more mutations are viable. In its final iterations, ProVADA generated a pool of novel candidates with a mean viral selection score of 2.72, consistently scoring highly viable variants while maintaining a diverse range of sequence similarity to the wildtype sequence. Our results show that ProVADA provides a powerful and efficient framework for accelerating the design of proteins with complex, user-defined properties.
Más Videos Relacionados
09:21Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors
Published on: January 29, 2019
09:20Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
Published on: October 18, 2022
Videos de Conceptos Relacionados
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.